NCT00277056终止不适用
Dysregulated Tyrosine Kinase Signaling in Leukemia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 30
- 试验地点
- 1
研究概览
简要总结
Dysregulated Tyrosine Kinase Signaling in Leukemia
详细描述
Purpose: to look at a number of proteins in the abnormal cells in the blood and/or bone marrow. These proteins make a cell grow or prevent the cell from dying
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must have newly diagnosed or relapsed leukemia.
- •Patients must sign an informed consent.
- •Patients will not be excluded if they are receiving chemotherapy.
- •Patients with CML, AML, ALL, T/NK leukemia, myelodysplasia, or myeloproliferative disorders will be eligible.
- •Patients must be => 18 years of age.
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Myeloid Derived Suppressor Cells and Chronic Myeloid LeukemiaChronic Myeloid Leukemia PatientsNCT03214718Assiut University50
招募中
不适用
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid LeukemiaTyrosine Kinase InhibitorPharmacokineticsTherapeutic Drug MonitoringNCT05259228National Taiwan University Hospital40
Unknown
不适用
A Study for Tyrosine Kinase Inhibitors DiscontinuationLeukemiaNCT02897245Versailles Hospital200
招募中
不适用
CML Pediatric ITK Response According to Molecular Identification at DiagnosisChronic Myeloid LeukemiaNCT05605379University Hospital, Bordeaux88
进行中（未招募）
1 期
Tyrosine kinase Inhibitors in DysplAsia of Lung epithelium Study 1 - TIDAL 1 Version 1.0EUCTR2010-023355-29-GBPapworth Hospital NHS Foundation Trust32